Immunogammagraphy with monoclonal antibodies against CEA and TAG-72 in the diagnosis of colorectal carcinoma;Inmunogammagrafía con anticuerpos monoclonales anti-CEA y anti-TAG-72 en el diagnóstico del carcinoma colorrectal

Medicina Clinica

Volumn 107, Issue 16, 1996, Pages 601-607

  Muxí Pradas, M África ^a,b   Pons Pons, Francisca ^a   Huguet Planella, Marina ^a   Novell Capilla, Francisco ^a   Herranz García Romero, Ramón ^a   Trias Folch, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN 72; TUMOR-ASSOCIATED ANTIGEN 72;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOIMMUNOASSAY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY;

EID: 3042933050     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pressman D, Korngold L. The in vivo localization of anti-Wagner osteogenic sarcoma antibodies. Cancer 1953; 6: 7.619-7.623.
2. Gold P, Freedman SO. Specific carcinoembryonic antigen of the human digestive system. J Exp Med 1965; 122: 467-481.
3. Köhler G, Milstein C. Continous culture of fussed cells secreting antibody of predefining specificity. Nature (Lond) 1975; 256: 495-497.
4. Goldenberg DM, DeLand K, Kim E, Bennett S, Primus FJ, Van Nagell JR Jr et al. Use of radiolabeled antibodies to carcinoembryonic antigen in the detection and localization of diverse cancers by external photoscanning N Engl J Med 1978; 298: 1.384-1.388.
5. Goldenberg DM, Kim EE, DeLand FH, Bennett S, Primus F. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2.984-2.992.
6. 111In-labeled Monoclonal Antibody Immunoscintigraphy in colorectal carcinoma: safety, sensitivity and preliminary clinical results. Radiology 1990; 175: 163-171.
7. Lind P, Lechner P, Arian-Schard K, Klimpfinger M, Cesnik H, Kammerhuber F et al. Anticarcinoembryonic antigen immunoscintigraphy (technetium-99mTc-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991; 32: 1.319-1.325.
8. 99mTc-labelled anti-CEA monoclonal antibody (BW 431/26). Nucl Med Comm 1992; 13: 261-270.
9. 111In-CYT 103 in the management of colorectal cancer: comparison with CT. Radiology 1992; 185: 179-186.
10. 111In-labelled antiTAG-72 monoclonal antibody. Nucl Med Comm 1993; 14: 775-787.
11. Abdel-Nabi H, Doerr RJ. Clinical applications of Indium-111-labeled monoclonal antibody in colorectal cancer patients. Semin Nucl Med 1993; 23: 99-113.
12. Perkins AC, Pimm MV. Imaging techniques. En: Perkins AC, Pimm MV, editores. Immunoscintigraphy. Practical aspects and clinical applications. Nueva York: Wiley-Liss, 1991; 91-109.
13. 111In-CYT-103; OncosCint CR-103) in patients with colorectal carcinoma. En: Maguire RT, Nostrand DV, editores. Diagnosis of colorectal and ovarian carcinoma. Application of immunoscintigraphy technology. Nueva York: Marcel Dekker Inc., 1992; 73-88.
14. Freeny DC, Marks WH, Ryan JD, Bolen JW. Colorectal cancer evaluation with CT. Preoperative staging and detection of preoperative recurrence. Radiology 1986; 158: 347-353.
15. Krestin GP, Steinbrich W, Friedmann G. Recurrent rectal cancer: diagnosis with MR imaging versus CT. Radiology 1988; 168: 307-311.
16. Collier DB, Foley D. Current Imaging strategies for colorectal cancer. J Nucl Med 1993; 34: 537-540.
17. Larson SM. Clinical radioimmunodetection. 1978-1988: overview and suggestions for standardization of clinical trials. Cancer Res 1990; 50: 892-898.
18. Galandiuk S. Immunoscintigraphy in the surgical management of colorectal cancer. J Nucl Med 1993; 34: 541-544.
19. Haseman MK, Brown DW, Keeling CA, Reed NL. Radioimmunodetection of occult carcinoembryonic antigen-producing cancer. J Nucl Med 1992; 33: 1.756-1.757.
20. Next hurdle for radiolabeled antibodies acceptance by medical insurers. Newsline J Nucl Med 1993; 34: 32N y 39N.
21. 111In labeled monoclonal antibody conjugate CYT-103. Gastrointest Radiol 1991; 16: 251-255.
22. 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies. Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr 1992; 157: 3-10.
23. Boven E, Haisma HJ, Bril M, Martens HJ, Van Linguen A, Den Hollander W et al. Tumor localization with 1311-labeled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients. Eur J Cancer 1991; 27: 1.430-1.436.
24. Haseman MK. Radioimmunodetection of occult cancer antibody, Immunoconjugate Radiopharm 1992; 5: 249-260.
25. 131I B72.3 monoclonal antibody. En: Maguire RT, Nostrand DV, editores. Diagnosis of colorectal and ovarian carcinoma. Application of immunoscintigraphy technology. Nueva York: Marcel Dekker Inc., 1992; 45-55.
26. Beatty JD, Hyams DM, Morton BD, Beatty BG, Williams LE, Yanauchi D et al. Impact of radiolabeled monoclonal antibody imaging on management of colon cancer. Am J Surg 1989; 157: 13-19.
27. Haseman MK, Brown DW, Keeling CA, Reed NL. Radioimmunodetection of occult Carcinoembryonic antigen producing cancer. J Nucl Med 1992; 33: 1.750-1.756.
28. Abdel-Nabi H, Chan HW, Doerr RJ. Indium-labelled anti-colorectal carcinoma monoclonal antibody in non-tumored tissue in patients with colorectal carcinoma. J Nucl Med 1990; 31: 1.975-1.979.
29. Davidson BR, Young H, Waddington NA, Babich J, Clarke GA, Short MD et al. Preoperative imaging of colorectal cancer targeting the epithelial membrane antigen with radiolabeled monoclonal antibodies Cancer 1992; 69: 620-625.
30. Goldenberg DM, Wlodkowski TJ, Sharkey RM, Silverstein EB. Serafini AN, Garty II et al. Colorectal cancer imaging with Iodine-123 labeled CEA monoclonal antibodies fragments. J Nucl Med 1993; 34: 61-70.
31. Markowitz A, Saleemi K, Freeman LM. Role of In-111 labeled Cyt-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma Clin Nucl Med 1993; 234: 685-700.
32. 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake, Int J Colon Dis 1989; 4: 97-108.
33. Moertel CG, Shutt AJ, Go VLV. Carcinoembryonic antigen test for recurrent colorectal cancer. Inadequacy for early detection. JAMA 1978; 239: 1.065-1.066.
34. Guadagni F, Roselli M, Amato T, Cosimelli M, Mannella E, Tedesco M et al. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. J Surg Oncol 1991; 2 (Supl): 16-20.
35. Rosandic-Pilas M, Hadzic N, Stavljenic A, Juricic M, Scukenec-Spoljar M. Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinoma. Acta Med Aust 1990; 17: 89-93.
36. Schnnebaum S, Arnold MW, Young D, La Valle GJ, Petty L, Berens MA et al. Role of carcinoembryonic antigen in predictin resectability of recurrent colorectal cancer. Dis Colon Rectum 1993; 36: 810-815.
37. Bosset K, Steinsträsser A, Schwarz A, Harthus HP, Lüben G, Kuhlman L et al. Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J Nucl Med 1988; 14: 523-528.